Search Results
Dr. Blackwell Discusses Margetuximab for HER2+ Breast Cancer
Dr. Kimberly L. Blackwell on a Promising HER2+ Breast Cancer Treatment
Dr. Blackwell on Treatment Landscape of HER2+ Breast Cancer
Dr. Pegram on Margetuximab Plus Chemo in HER2+ Breast Cancer
Dr. Blackwell on the Impact of the CLEOPATRA and MARIANNE Studies in HER2+ Breast Cancer
Dr. Blackwell on Neratinib in HER2+ Breast Cancer
Margetuximab Plus Chemotherapy in HER2+ Breast Cancer
Dr. Blackwell on Late Recurrences in Patients With Breast Cancer
Dr. Rugo on the Phase III SOPHIA Trial in HER2+ Breast Cancer
Dr. Blackwell on Emerging Therapies in TNBC
Kimberly Blackwell, MD: Choices of Therapy
Kimberly Blackwell, MD: Choices of Therapy in Breast Cancer
